MedTrace Logo

Effects of Multilac Baby on Fecal Calprotectin Levels of Colicky Babies

NCT04666324 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-12-14

No results posted yet for this study

Summary

Open trial with two parallel arms, assessing the effects of Simethicone and Multilac Baby on crying behavior and fecal calprotectin levels in babies diagnosed for infantile colic.

Conditions

  • Infantile Colic

Interventions

DRUG

Simethicone Solution

Oral daily treatment for four weeks

DIETARY_SUPPLEMENT

Multilac Baby

Oral daily treatment for four weeks

Sponsors & Collaborators

  • The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz

    lead OTHER

Principal Investigators

  • Hanna Krauss, Prof. · The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Weeks
Max Age
6 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-31
Primary Completion
2021-06-30
Completion
2021-09-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04666324 on ClinicalTrials.gov